EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 28, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Nonfunctional Pancreatic Neuroendocrine TumorPancreatic Neuroendocrine TumorEndoscopic Ultrasound
Interventions
PROCEDURE

EUS-guided ethanol ablation

After puncturing with the needle, 95% ethanol under the guidance of EUS was injected into the tumor. The injection volume of ethanol was estimated according to the following principles: (1) The injection volume was not larger than the tumor spherical volume. (2) Injection volume was reduced when the tumor was adjacent to the pancreatic duct or vessel. (3) Injection volume for the lesions with repeated EUS-FNI was reduced.

PROCEDURE

EUS-guided lauromacrogol ablation

After puncturing with the needle, lauromacrogol under the guidance of EUS was injected into the tumor. The injection volume of lauromacrogol was estimated according to the following principles: (1) The injection volume was not larger than the tumor spherical volume. (2) Injection volume was reduced when the tumor was adjacent to the pancreatic duct or vessel. (3) Injection volume for the lesions with repeated EUS-FNI was reduced.

Trial Locations (1)

530021

RECRUITING

First Affiliated Hospital of Guangxi Medical University, Nanning

All Listed Sponsors
lead

Guangxi Medical University

OTHER